Search

Presents the instructions to contributors for the submission of manuscripts. Number of copies of the paper to be submitted; Amount of words for the abstracts of the paper; Types of information about the author.

The article presents notes for contributors in the submission of manuscripts and its style. Three complete copies of the authors' paper should by submitted, with author name omitted for double-blind review to the journal editor John B. Davis. Typed in double spacing on one side only of the paper, submission should be in English. Submission of a paper to a journal will be taken to entail that it presents original, unpublished, work not under condition for publication in or to another place. In addition, an abstract of the paper is required, of up to 150 words that should precede the article. Other guidelines related to the matter are presented.

The article presents notes for contributors in the submission of manuscripts. Three complete copies of the authors' paper should by submitted, with author name omitted for double-blind review to the journal editor John B. Davis. Typed in double spacing on one side only of the paper, submission should be in English. Submission of a paper to a journal will be taken to entail that it presents original, unpublished, work not under condition for publication in or to another place. In addition, an abstract of the paper is required, of up to 150 words that should precede the article. Other guidelines related to the matter are presented.

Nurse scientists are increasingly interested in conducting secondary research using real world collections of biospecimens and health data. The purposes of this scoping review are to (a) identify federal regulations and norms that bear authority or give guidance over reuse of residual clinical biospecimens and health data, (b) summarize domain experts' interpretations of permissions of such reuse, and (c) summarize key issues for interpreting regulations and norms. Final analysis included 25 manuscripts and 23 regulations and norms. This review illustrates contextual complexity for reusing residual clinical biospecimens and health data, and explores issues such as privacy, confidentiality, and deriving genetic information from biospecimens. Inconsistencies make it difficult to interpret, which regulations or norms apply, or if applicable regulations or norms are congruent. Tools are necessary to support consistent, expert-informed consent processes and downstream reuse of residual clinical biospecimens and health data by nurse scientists. [ABSTRACT FROM AUTHOR]

The article presents instructions for authors to send their manuscripts on related topics to pediatrics and adolescent medicine. Manuscripts are considered with the understanding that they have not been published previously in print or electronic format and are not under consideration by another publication or electronic medium. Copies of possibly duplicative material that has been previously published or is being considered elsewhere must be provided at the time of manuscript submission. Manuscripts may be submitted via e-mail also. Print mail address and telephone and fax numbers of the corresponding author also should be included on the title page of the manuscript.